(NASDAQ: FEMY) Femasys's forecast annual revenue growth rate of 177.96% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.21%.
Femasys's revenue in 2026 is $2,061,502.On average, 5 Wall Street analysts forecast FEMY's revenue for 2026 to be $386,259,238, with the lowest FEMY revenue forecast at $253,626,997, and the highest FEMY revenue forecast at $552,634,337. On average, 4 Wall Street analysts forecast FEMY's revenue for 2027 to be $1,283,105,818, with the lowest FEMY revenue forecast at $787,781,709, and the highest FEMY revenue forecast at $1,797,611,310.
In 2028, FEMY is forecast to generate $2,674,399,311 in revenue, with the lowest revenue forecast at $1,551,177,332 and the highest revenue forecast at $3,844,171,231.